#127 Nocturnal polyuria and nocturnal arginine vasopressin (AVP): a key factor in the patho-physiology of monosymptomatic nocturnal enuresis

#128 Vesicostomy as a protection of the upper urinary tract on long follow up and the associated lifestyle adjustments of patient’s caretaker

#129 Interstim Implants in the Pediatric Population

#130 ALTERED MODULATION OF ADRENERGIC SIGNALING BY SMOOTH MUSCLE CAVEOLAE IN DETRUSOR OVERACTIVITY

#131 Microcirculation in the urinary bladder wall in OAB female patients

#132 Routine MSU culture in patients with symptoms of OAB may be missing many genuine infections

#133 BOTOX® FOR IDIOPATHIC OVERACTIVE BLADDER PATIENTS REFRACTORY TO ANTIMUSCARINIC THERAPY IN THE ABSENCE OF DETRUSOR OVERACTIVITY

#134 Patient-selected goals in overactive bladder: a placebo controlled randomised double-blind trial of transdermal oxybutynin for the treatment of urgency and urge incontinence